8-K: Astrana Health Secures Amended Credit Agreement with $1.3 Billion Facility

Astrana Health, Inc. enters into a second amended and restated credit agreement providing a $1.3 billion credit facility to refinance debt, cover transaction costs, and fund acquisitions.

Summary

• Astrana Health, Inc. has entered into a second amended and restated credit agreement on February 26, 2025.
• The agreement provides a $300 million revolving credit facility, a $250 million term loan A credit facility, and a $745 million delayed draw term loan credit facility, totaling $1.3 Billion.
• The credit facilities will be used to refinance existing debt, cover transaction costs, and provide working capital.
• The delayed draw term loan will finance the acquisition of assets contemplated by the asset and equity purchase agreement dated November 8, 2024, with Prospect Medical Holdings, Inc.
• The company is required to pay commitment fees and ticking fees on the unused portions of the credit facilities, determined quarterly based on the company's leverage ratio.
• Interest rates on borrowed amounts will be based on either term SOFR plus a spread of 1.25% to 2.50% or a base rate plus a spread of 0.25% to 1.50%, depending on the company's leverage ratio.
• The agreement includes affirmative and negative covenants, including restrictions on liens, indebtedness, investments, and distributions.
• The company must maintain a maximum consolidated total net leverage ratio and a minimum consolidated interest coverage ratio, commencing with the fiscal quarter ending June 30, 2025.
• The lenders have a security interest in all of the company's assets.
• The company's Board of Directors has set June 11, 2025, as the date for the 2025 Annual Meeting of Stockholders, which will be held virtually.
• The record date for stockholders eligible to vote at the 2025 Annual Meeting was set for April 22, 2025.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining a significant credit facility that supports the company's growth strategy. However, it also includes risks and restrictions associated with debt financing.

Positives

• Securing a significant credit facility provides Astrana Health with financial flexibility.
• Refinancing existing debt can potentially lower interest expenses and improve cash flow.
• The delayed draw term loan enables the company to pursue strategic acquisitions.
• The revolving credit facility provides access to working capital and supports future investments.

Negatives

• The credit agreement includes restrictive covenants that could limit the company's operational flexibility.
• Failure to comply with financial covenants could trigger an event of default.
• The company will incur commitment fees and ticking fees on the unused portions of the credit facilities.
• The company's assets are pledged as security for the credit facilities.

Risks

• Changes in the company's leverage ratio could impact interest rates and fees.
• The company's ability to meet financial covenants is subject to business and economic conditions.
• The acquisition of assets from Prospect Medical Holdings, Inc. may not be successful.
• Adverse economic conditions could impact the company's ability to repay its debt.

Future Outlook

The credit facilities will be used to finance future permitted acquisitions and investments, provide working capital, and for other general corporate purposes.

Industry Context

This announcement reflects a trend in the healthcare industry where companies are leveraging debt financing to fund acquisitions and growth initiatives. The credit agreement provides Astrana Health with the capital necessary to execute its strategic plans and expand its market presence.

Comparison to Industry Standards

• Comparable companies in the healthcare services sector, such as Oak Street Health (OSH) and Agilon Health (AGL), also utilize debt financing to support their growth strategies.
• The leverage ratios and interest coverage ratios outlined in the credit agreement are within industry norms for companies of similar size and risk profile.
• The interest rates and fees associated with the credit facilities are competitive with those offered by other lenders in the market.

Stakeholder Impact

• Shareholders: The credit facility supports the company's growth strategy, which could lead to increased shareholder value.
• Employees: The company's financial stability is enhanced by the credit facility, which could provide job security.
• Customers: The company's ability to invest in its business could lead to improved services for customers.
• Suppliers: The company's financial stability could ensure timely payments to suppliers.
• Creditors: The credit facility provides the company with the resources to meet its debt obligations.

Next Steps

• The company will use the delayed draw term loan to finance the acquisition of assets from Prospect Medical Holdings, Inc.
• The company will need to comply with the financial covenants outlined in the credit agreement.
• The company will hold its 2025 Annual Meeting of Stockholders on June 11, 2025.

Key Dates